Peptides are at a sweet spot in biochemistry, small enough to be synthesized with precision, yet complex enough to interact with biological systems in some meaningful way. To study them, the toolkit needs to cover the fields of chemistry, molecular biology and pharmacology. Knowing these basic techniques provides insight into how scientists could go from a synthetic peptide to real knowledge of what it does and whether it is potentially useful.
The Synthesis and Structural Verification Was Conducted as Step One. Synthesis and Structural Verification Were Carried Out for Step One.
Researchers must have a US manufactured research use only peptides that is chemically proven to be what it is before any biological testing can take place. The majority of research peptides are synthesized by solid-phase peptide synthesis (SPPS) in which individual amino acids are sequentially coupled to a chain that is attached to a solid resin. This way, the sequence and length can be controlled with accuracy.
The peptide is then synthesized and has to be verified and purified. High-performance liquid chromatography (HPLC) is used to separate and purify the target peptide from synthesis by-products and to check for purity. A molecular weight of the compound is then measured by mass spectrometry, which is similar to a fingerprint of the molecule to confirm that the known compound is the one found. If they did not have this verification step, any subsequent biological results would be invalid because they would not have known what they had tested.
Step Two: In Vitro Studies
The next phase usually occurs in the lab, "in glass" (in vitro) in cell cultures or isolated biological systems. Common approaches include:
Radiolabeling or fluorescent labeling of peptides is used in receptor binding assays to measure the strength and specificity of binding to the peptide's target receptor; this approach is used to watch the binding of radiolabeled or fluorescently tagged peptides in real time.
Cell-based functional assays involve the direct exposure of living cells to a peptide and the subsequent consequences; changes in gene expression, release of hormones, activation of cell signaling pathways, or cell survival and proliferation.
Enzyme assays, where a peptide is designed to inhibit or activate a particular enzyme; an activity is measured in a controlled, cell free environment.
The work done in vitro is relatively quick, cheap, and offers the researcher the possibility of testing numerous peptide combinations before embarking on more costly studies. The major drawback is that it cannot faithfully recapitulate the complexity of the whole organism because metabolism, distribution in the body, immune response etc are not included.
The Next Step Is in Vivo Animal Studies.
Promising peptides in vitro have progressed to in vivo studies, usually in rodents. These studies address issues which cannot be answered in cell culture: Absorption, distribution, metabolism, and elimination of the peptide (pharmacokinetics)? At what dose does a measurable effect occur and at what dose do toxic effects occur? How does the peptide affect if it is taken orally, by injection or otherwise?
Animal studies are performed under the strict constraints of animal ethics, and are normally approved by animal care and/or use committees within the institutions where the studies are conducted, which have to approve animal research by considering the animal welfare and the reduction of animal use and the design of the study. Various outcomes, such as organ toxicity, changes in behavior and physiological parameters which are relevant to the peptide's working mechanism, are monitored.
The Fourth Step Involves Analytical and Stability Testing. The Fourth Step Is Analytical and Stability Testing.
A peptide's stability – the way it breaks down at various temperatures, pH levels, and storage conditions – is also examined as part of the process, as peptides are generally less chemically stable than small-molecule drugs. This is done repeatedly using techniques such as mass spectrometry and chromatography to monitor degradation products and shelf life, both for research reproducibility and in case of eventual formulation in a real application.
As You Can See, It Is a Five-Step Procedure. As You Can See, It Is a Five-Step Procedure.
Once there is evidence in the preclinical studies and a regulatory body approves the compound for human trials, peptides enter a series of human trials, at first to closely see how safe the peptide is for humans, then to monitor its effectiveness and possible side effects in increasingly larger numbers of people. This is the only stage to really determine the actions of the peptide in human bodies, as data from animals and cells are also useful, but not always directly applicable to human physiology.
This Process Is Important Because –
These stages are in place to address different questions about a compound; if any of the stages are omitted, there are significant knowledge gaps. The receptor binding data for a peptide in a petri dish may be very good and the in vivo data could show that the same peptide is completely inactive or rather is unexpectedly toxic in an animal model system. Good peptides in rodents may not be as effective in humans because of metabolic or immune differences between the species. For this reason, reliable claims on the effects of a peptide must be linked to one particular stage of evidence (in vitro, animal or human) and should not be confused with one another.
The Bottom Line
The scientific study of a peptide involves several steps: chemical synthesis and verification, cell-based testing, animal testing, stability analysis and, if it reaches that point, human clinical trials. The process at each stage removes compounds from the system that are not retained, and produces a more complete picture of the actual behaviour of a peptide in a biological system. The best way to assess the real state of knowledge about a particular peptide is to know what stage of the process has it reached.